Customer satisfaction in the business-to-business (B2B) world is essential to company success. The stakes are particularly high in areas like pharmacy benefit managers (PBMs). PBMs…
As both consumers and providers of healthcare services, hospitals and health systems have a unique ability to lower pharmaceutical costs for their employees while keeping…
For years, rebates have been a dominant factor in the drug pricing equation for plan sponsors. To maintain affordability, employers have had to accept a supply…
For the past eight years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit designs used by employers, unions,…
The prescription drug market is changing yet again, creating an ideal opportunity for plan sponsors to evaluate vendor options for pharmacy benefit management (PBM). Examples…
For the last eight years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit designs used by employers, unions,…
Drug rebates are big business. According to life sciences analytics firm IQVIA, pharmaceutical manufacturers offered $153 billion in rebates and discounts in 2017. That’s double…
Rising prescription drug costs are a major concern in the United States, especially the effect these increases are having on individual patients who are on…
On January 31, the Trump Administration released a proposal that would require pharmacy benefit managers (PBMs) and insurers to pass through 100% of Medicare rebates to…
Controlling specialty drug costs and trends takes constant and careful vigilance. Yet many plan sponsors lack the tools or expertise to monitor integrated member spend…
The United States could face a serious shortage of both primary and specialty care physicians by 2030—up to 120,000, according to research from the Association of…